ST-1898

· Beijing Scitech-Mq Pharmaceuticals Limited

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ST-1898, covering 2025-08-24 to 2025-08-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer [Phase 2]